Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
City Holding Co
CHCO
$2.05B
| $21M | ﹤0.01% |
279,094
+2,497
| +0.9% | +$197K |
|
1927
ImmunityBio
IBRX
$7.49B
| $21M | ﹤0.01% |
1,469,696
+805,147
| +121% | +$13.3M |
|
1928
Inogen
INGN
$182M
| $21M | ﹤0.01% |
321,743
+17,924
| +6% | +$1.13M |
|
|
HA
1929
DELISTED
Hawaiian Holdings, Inc.
HA
| $21M | ﹤0.01% |
859,778
+65,360
| +8% | +$1.69M |
|
1930
TriCo Bancshares
TCBK
$1.85B
| $20.9M | ﹤0.01% |
491,541
+17,984
| +4% | +$834K |
|
1931
NETGEAR
NTGR
$648M
| $20.9M | ﹤0.01% |
544,345
+7,706
| +1% | +$299K |
|
|
CVAC
1932
DELISTED
CureVac
CVAC
| $20.9M | ﹤0.01% |
283,817
+144,331
| +103% | +$14.4M |
|
1933
FB Financial Corp
FBK
$3.05B
| $20.8M | ﹤0.01% |
558,455
+47,335
| +9% | +$1.96M |
|
1934
Clearway Energy Class C
CWEN
$4.99B
| $20.8M | ﹤0.01% |
785,315
-588,302
| -43% | -$16.1M |
|
1935
Veeco
VECO
$3.11B
| $20.8M | ﹤0.01% |
864,291
+39,806
| +5% | +$912K |
|
1936
CTS Corp
CTS
$1.86B
| $20.7M | ﹤0.01% |
557,901
+22,241
| +4% | +$766K |
|
1937
BCE
BCE
$20.3B
| $20.7M | ﹤0.01% |
401,689
-95,302
| -19% | -$4.62M |
|
1938
Employers Holdings
EIG
$910M
| $20.7M | ﹤0.01% |
484,091
+7,675
| +2% | +$319K |
|
1939
Southern Copper
SCCO
$146B
| $20.7M | ﹤0.01% |
350,078
+2,908
| +0.8% | +$189K |
|
|
CNST
1940
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $20.7M | ﹤0.01% |
611,273
+49,428
| +9% | +$1.26M |
|
|
PRA
1941
DELISTED
ProAssurance
PRA
| $20.7M | ﹤0.01% |
907,980
+7,294
| +0.8% | +$184K |
|
|
VIVO
1942
DELISTED
Meridian Bioscience Inc
VIVO
| $20.7M | ﹤0.01% |
931,303
+23,106
| +3% | +$490K |
|
1943
CoreCivic
CXW
$3B
| $20.7M | ﹤0.01% |
1,972,550
+45,044
| +2% | +$404K |
|
|
CSR
1944
Centerspace
CSR
$932M
| $20.5M | ﹤0.01% |
260,416
+9,615
| +4% | +$692K |
|
|
NXGN
1945
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $20.5M | ﹤0.01% |
1,238,448
+33,915
| +3% | +$608K |
|
|
USCR
1946
DELISTED
U S Concrete, Inc.
USCR
| $20.5M | ﹤0.01% |
278,081
+5,218
| +2% | +$338K |
|
1947
Alector
ALEC
$168M
| $20.4M | ﹤0.01% |
980,607
+131,612
| +16% | +$2.48M |
|
1948
Melco Resorts & Entertainment
MLCO
$2.17B
| $20.4M | ﹤0.01% |
1,257,927
+82,204
| +7% | +$1.49M |
|
|
NVEE
1949
DELISTED
NV5 Global
NVEE
| $20.4M | ﹤0.01% |
863,036
+126,728
| +17% | +$2.88M |
|
1950
Archrock
AROC
$6.16B
| $20.3M | ﹤0.01% |
2,282,593
+181,356
| +9% | +$1.69M |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.